US SEC Filings Daily Market Digest — October 20, 2026

19-10-2026

Archimedes Tech SPAC Partners II Co. (ATII) shareholders approved the business combination with Forge Nano, Inc. at an extraordinary general meeting held October 16, 2026, with 16,530,280 ordinary shares (55.9% of 29,590,000 outstanding) represented. All seven proposals, including the Business Combination Proposal (15,416,866 FOR vs. 1,113,414 AGAINST), the Domestication Merger, the director slate, the stock issuance, and the equity incentive plan, were approved. Pubco will be renamed Forge Nano Holdings, Inc. upon closing, and some advisory governance proposals drew more substantial opposition (for example, 2,065,390 AGAINST on the authorized share increase).

• · Proposal 6A (Authorized Shares) received 2,065,390 AGAINST votes, the largest opposition among the advisory governance proposals
• · Director elections for Paul Lichty and Ben Landen each drew about 1.5 million AGAINST votes, more than the roughly 1.1 million AGAINST for the other nominees
• · Advisory proposals 6B through 6F each drew roughly 2.07 million AGAINST votes, indicating a consistent minority objection to the Proposed Charter provisions
• · The Registration Statement on Form S-4 was declared effective by the SEC on September 22, 2026, and the Definitive Proxy Statement was filed September 24, 2026
• · The merger agreement was originally entered into April 20, 2026 among ATII, Pubco, Merger Sub I, Merger Sub II, and Forge Nano, Inc.
• · The filing furnishes a press release (Exhibit 99.1) announcing shareholder approval, and that furnished information is not deemed filed under Section 18 of the Exchange Act

19-10-2026

BSR Real Estate Investment Trust filed a Form 6-K on October 19, 2026 (signed October 16, 2026) furnishing a Notice of Change of Auditor as Exhibit 99.1, along with a Former Auditor Response Letter (Exhibit 99.2) and a Successor Auditor Response Letter (Exhibit 99.3). The filing is an administrative governance disclosure with no financial results, amounts, or operating metrics disclosed in the body provided. The registrant is a Form 40-F filer, indicated by the checked box.

• · Commission File Number 001-43491
• · Registrant's principal executive office is at 333 Bay Street, Suite 3400, Toronto, Ontario, and the filing lists a (501) telephone number
• · Filing is made under Rule 13a-16 / 15d-16 for the month of October 2026
• · Financial statements, auditor names, and reasons for the auditor change are not included in the provided text and would reside in the referenced exhibits

19-10-2026

Emera Incorporated filed a Form 6-K for October 2026 furnishing Exhibit 99.1, a Material Change Report dated October 16, 2026, which is incorporated by reference into its Form F-10 and Form F-3 registration statements. The filing body itself contains no financial figures, operational details, or description of the material change; the substance resides in the referenced exhibit, which was not included in the provided content.

• · Filing type is Form 6-K under Rule 13a-16/15d-16 for the month of October 2026, Commission File No. 001-42631.
• · Registrant is a Form 40-F filer (Form 20-F box unchecked), indicating MJDS eligibility.
• · Exhibit 99.1 (Material Change Report dated October 16, 2026) is incorporated into Form F-10 (File Nos. 333-291985, 333-294020) and Form F-3 (File Nos. 333-294017, 333-294017-01, 333-294017-02), suggesting the disclosed change may be relevant to pending or active securities offerings.
• · Principal executive offices are located at 5151 Terminal Road, Halifax, Nova Scotia, Canada.

19-10-2026

GreenPower Motor Company Inc. furnished a Form 6-K for October 2026 under Rule 13a-16, submitting as Exhibit 99.1 a press release dated October 16, 2026. The filing itself is a cover document containing no financial figures, and its substance is contained in the attached press release, which was not included in the provided content. The 6-K was signed by CFO Michael Sieffert.

• · Commission File Number 001-39476; registrant headquartered at #240 - 209 Carrall Street, Vancouver, British Columbia V6B 2J2
• · Registrant files annual reports on Form 20-F (not Form 40-F)
• · Attached Exhibit 99.1 is a press release dated October 16, 2026, whose content is not reproduced in the provided text

19-10-2026

Phaos Technology Holdings (Cayman) Limited filed its annual report on Form 20-F for the fiscal year ended April 30, 2026, announced via a press release dated October 16, 2026, which is furnished as Exhibit 99.1 to this Form 6-K. The filing is a procedural disclosure that references the annual report and financial results but does not itself disclose the financial figures, which are contained in the press release and the 20-F.

• · Fiscal year ended April 30, 2026 is the period covered by the annual report and financial results
• · Company principal executive office is located at 55 Ayer Rajah Crescent #05-05, Singapore 139949
• · Commission File Number 001-42952
• · Company files annual reports on Form 20-F rather than Form 40-F

19-10-2026

POET Technologies Inc. furnished a Form 6-K on October 19, 2026 (signed October 16, 2026) attaching a press release dated October 16, 2026 as Exhibit 99.1. The filing itself contains no quantitative disclosures; its substance is entirely incorporated by reference to the attached press release, which was not included in the content provided.

• · Filing is a Form 6-K for the month of October 2026 by a foreign private issuer that files annual reports on Form 20-F
• · Commission File Number 000-55135; principal executive office at 120 Eglinton Avenue East, Suite 1107, Toronto, Ontario, Canada
• · Exhibit 99.1 (press release dated October 16, 2026) is incorporated by reference but its contents are not included in the provided filing text, so no financial figures, product news, or strategic details can be verified from this document
• · Recommend retrieving Exhibit 99.1 to determine the substantive subject matter before assigning materiality or Instagram suitability

19-10-2026

TC Energy Corporation furnished a Form 6-K under the Exchange Act for October 2026, attaching as Exhibit 99.1 a copy of its news release dated October 16, 2026. The filing itself is a cover document signed by Jane M. Brindle, Vice-President, Law and Corporate Secretary, and contains no financial results, transactions, or regulatory actions. The substantive content lies in the referenced news release, which is not reproduced in the text provided.

• · Registrant files annual reports on Form 40-F rather than Form 20-F.
• · Commission File No. 1-31690; principal executive offices at 450 – 1 Street S.W., Calgary, Alberta, Canada.
• · Exhibit 99.1 (news release dated October 16, 2026) is furnished, not filed, and is not incorporated by reference into Securities Act registration statements.
• · The provided content does not include the text of the October 16, 2026 news release, so no financial or operational details can be verified from this filing.

19-10-2026

STARRY SEA ACQUISITION CORP (SSEAR) filed a DEFA14A soliciting-material notice (dated October 16, 2026) updating shareholders on its Extraordinary General Meeting in lieu of an annual general meeting. The meeting, originally set for October 9, 2026, was postponed to October 19, 2026 to allow more time for shareholder engagement. Redemption requests were withdrawn for 601,847 public shares, while 3,895,270 public shares remain tendered for redemption, a development that bears directly on the vote outcome and the company's remaining trust capital.

• · Meeting originally scheduled for 10:00 a.m. ET on October 9, 2026, postponed to 9:00 a.m. ET on October 19, 2026
• · Public shareholder redemption deadline expired at 5:00 p.m. ET on October 15, 2026
• · Net tendered redemptions of 3,895,270 shares remain after withdrawals, indicating substantial shareholder redemption intent
• · Company is an Emerging Growth Company incorporated in the Cayman Islands, a SPAC-style blank check vehicle with units, shares, and rights listed on Nasdaq

19-10-2026

Vail Resorts filed soliciting material under Rule 14a-12 (DEFA14A) on October 19, 2026, containing a company statement issued October 15, 2026 in response to journalist inquiries, including a Denver Business Journal article. The statement cites management's 16-month transformation effort, record guest satisfaction last year, increased lift ticket market share, and outperformance versus the industry on upcoming season pass sales, while noting the forward-looking Epic Experience growth strategy. The filing is connected to the company's solicitation of proxies for its 2026 annual meeting, and no specific financial figures were disclosed.

• · The filing is tied to a proxy solicitation for the 2026 annual meeting, with a WHITE proxy card referenced, indicating an active shareholder proxy contest or contested governance situation
• · The company cites outperformance versus the industry on pass sales for the upcoming season but provides no quantitative figures
• · The 2025 annual meeting proxy statement was filed with the SEC on October 30, 2025
• · No dollar amounts, earnings figures, or period-over-period financial metrics are disclosed in this filing

19-10-2026

Healthy Choice Wellness Corp. (renamed Host Digital Inc., NYSE American ticker changed from HCWC to HOST effective September 18, 2026) filed a Form S-3 registration statement to register for resale by Selling Stockholders up to 45,385,000 shares of Class A common stock, following its September 17, 2026 business combination with Host LLC, which became a wholly owned subsidiary. The company also raised approximately $17.5 million gross from a public offering of 2,187,500 shares at $8.00 per share, completed September 21, 2026, while its legacy natural and organic grocery retail operations continue as a division. The registration creates potential dilution and selling pressure, which the filing explicitly flags as a risk to the share price.

• · Company is shifting from a natural grocery/wellness business to an AI and high-performance computing data center platform, with on-grid and behind-the-meter power strategies
• · Selling Stockholders' resale of up to 45,385,000 shares is more than 20 times the 2,187,500 shares sold in the September offering, a significant dilution overhang
• · Company will receive no proceeds from resale of registered shares; proceeds from Pre-Funded Warrant exercises would be nominal (~$1,989)
• · Filing references a Form 10-Q/A filed August 18, 2026 and an 8-K filed September 17, 2026 as incorporated documents
• · Company elected not to opt out of the JOBS Act extended transition period and claims emerging growth company and smaller reporting company status

19-10-2026

Powerus Corporation (formerly Aureus Greenway Holdings Inc., Nasdaq: PUSA) filed an S-3 registration statement covering the resale by selling stockholders of up to 7,409,209 shares of common stock. The Company receives no proceeds from these resales. The registrant completed its business combination with Autonomous Power Corporation (dba Powerus) on October 1, 2026, and now operates an autonomous systems and defense technology business alongside its legacy golf country club segment in Florida.

• · Merger Agreement signed March 8, 2026; business combination completed October 1, 2026, with the Company renamed Powerus Corporation.
• · Company receives no proceeds from the selling stockholders' sales; proceeds go to general corporate purposes only if the Company sells securities under the shelf.
• · Company has never paid cash dividends and does not anticipate doing so for the foreseeable future.
• · Risk factors flag dilution from future offerings and potential selling pressure on the stock price once the resale shares become tradable.
• · Filing incorporates by reference the FY2025 10-K, Q1 and Q2 2026 10-Qs, and numerous 8-Ks from February through October 2026, plus S-4 audited financials for Autonomous Power Corporation, Kaizen Aerospace, and Agile Autonomy.
• · Filing date discrepancy: the header states the registration was filed October 16, 2026, while the metadata lists October 19, 2026.

19-10-2026

Sonic Holdco, Inc. (Parent) filed an amended S-4 registration statement/proxy statement/prospectus for a two-step reverse recapitalization under a new holding company that combines Synlogic, Inc. (a non-operating shell with discontinued product development, delisted from Nasdaq) and Caldera (an early clinical-stage biopharmaceutical company with no product revenue and significant ongoing net losses). The proposed transaction is conditioned on NYSE American listing approval, a concurrent financing, and Section 351(a) tax treatment, and carries material execution, dilution, and profitability risks.

• · Parent expects to trade on NYSE American under the proposed symbol 'CALD' following closing; listing approval is a closing condition that may be waived by the parties without re-solicitation.
• · The Mergers are expected to be accounted for as a reverse recapitalization, with Caldera treated as the accounting acquirer of Synlogic.
• · Exchange ratios are fixed and will not adjust for changes in Synlogic's market price.
• · Synlogic has identified a material weakness in internal control over financial reporting as of December 31, 2025.
• · Parent is an emerging growth company and will rely on JOBS Act accommodations, including reduced disclosure and extended accounting transition periods.
• · Caldera is substantially dependent on CLD-423, its only product candidate, a bispecific antibody with limited clinical and regulatory precedent.
• · Synlogic stockholders and Caldera stockholders are entitled to appraisal rights under Section 262 of the DGCL.
• · Synlogic's board may pursue dissolution and liquidation if the Mergers are not completed and no superior alternative exists.

20-10-2026

Innate Pharma S.A. (IPHYF) furnished a Form 6-K dated October 20, 2026, attaching a press release dated the same day as Exhibit 99.1. The filing itself is a cover-and-signature document under Rule 13a-16 and contains no financial figures, operational updates, or other substantive disclosures within the body text; the substance resides in the referenced press release, which was not included in the content provided.

• · The filing lists Form 20-F as the annual report form, indicating Innate Pharma is a foreign private issuer filing under 20-F rather than 40-F
• · Commission File Number 001-39084 and principal executive office located at 117 Avenue de Luminy, 13009 Marseille, France
• · Exhibit 99.1 (Press Release dated October 20, 2026) is referenced but its content is not included in the provided filing text and should be reviewed for substantive disclosures

20-10-2026

Peoples Bancorp reported Q3 2026 net income of $32.6 million, or $0.91 per diluted share, up from $28.0 million ($0.78) in Q2 2026 but up only modestly from $29.5 million ($0.83) in Q3 2025, with non-core items reducing EPS by $0.13. Net interest margin rose to 4.31% from 4.23% linked quarter, while net losses on securities sales ($4.8 million) and acquisition-related expenses weighed on results. The company also disclosed two pending acquisitions: Citizens National Corporation (approximately $76.6 million, cash and stock) and Capital Bancorp, Inc. (approximately $728.1 million, all stock), announced September 30, 2026.

• · Net interest income rose 3% year over year, while the provision for credit losses fell to $3.6M from $4.7M linked quarter and $7.3M a year earlier.
• · Accretion income from acquisitions declined to $1.0M from $1.7M a year earlier, shrinking its margin contribution from eight to four basis points.
• · Non-core items reduced Q3 2026 EPS by $0.13, versus $0.18 in Q2 2026 and $0.07 in Q3 2025, so the year-over-year EPS gain is smaller than the headline suggests on a core basis.
• · First nine months 2026 provision for credit losses was $18.0M, down from $34.1M in the same period of 2025, and net losses on securities reached $13.9M versus $3.7M.
• · Non-interest expense rose $4.6M year over year, driven by professional fees tied to acquisitions, salaries, and operating lease expense.
• · Capital Bancorp consideration is all stock, which may dilute existing shareholders, while the Citizens transaction includes both cash and stock.

20-10-2026

NuCube Energy announced a $25 million direct investment from the Alaska Industrial Development and Export Authority (AIDEA), a state-backed investor and the anchor investor in NuCube's current financing. AIDEA agreed to purchase Class A ordinary shares at $9.25 per share, an approximately 14.5% discount to the $10.82 reference price used for the exchange ratio in NuCube's business combination with Launch Two Acquisition Corp. (NASDAQ: LPBB). The investment counts as a Transaction Financing toward the $75 million Minimum Cash Condition for closing. The filing is a Rule 425 communication tied to the pending SPAC merger, with the share sale priced below the reference price and no reported earnings or revenue results.

• · The AIDEA investment is priced at a roughly 14.5% discount to the reference price, a material dilution-related term not reflected in the headline figure.
• · AIDEA also receives one-half warrant per share exercisable at $11.50 within 5 years.
• · The Business Combination Agreement dated June 25, 2026 was amended on October 19, 2026.
• · The Form S-4 registration statement was filed September 11, 2026 and has not yet become effective; securities cannot be sold until effectiveness.
• · The combined company is expected to list on Nasdaq upon closing, subject to listing requirements and closing conditions.

20-10-2026

Shinhan Financial Group disclosed the cancellation of 6,538,515 common shares acquired under a Board of Directors resolution dated July 23, 2026, plus one additional treasury share held in respect of a fractional share, which the same Board also resolved to cancel. The estimated cancellation amount in KRW is based on the book value of the shares as of the filing date. The filing is an amendment to a prior 6-K and contains no income statement or period-over-period performance metrics.

• · The cancellation covers both shares acquired under the July 23, 2026 Board resolution and one fractional-share treasury share, both approved for cancellation by the same Board resolution
• · The estimated KRW cancellation amount is stated at current book value as of the disclosure filing date rather than at acquisition cost

20-10-2026

Radiopharm Theranostics Ltd filed a 6-K reporting Appendix 3Y-style director interest notices for changes dated 16 October 2026 across multiple insiders, all involving the cancellation of listed options (EXP 31 Jul 2029, exercise price $0.018) with no shares acquired and no cash consideration. Direct and indirect holdings are reported before and after the change, with the aggregate post-change holding showing 150,499,206 shares and 36,826,185 options. The filing is administrative in nature and does not disclose a new capital raise, acquisition, or new share issuance.

• · Three reporting entries show cancellation of listed options dated 16 October 2026, with no shares acquired and nil consideration.
• · Sundial Management Pty Limited, of which Mr Goodwin is a Director and Shareholder, held 2,777,778 shares and 2,777,778 options before the change and disposed of 1,111,111 listed options.
• · The superannuation fund entry reports 9,010,253 indirect and 3,752,817 direct shares pre-change, with 1,111,111 listed options disposed.
• · Post-change aggregate reported holdings are 150,499,206 shares and 36,826,185 options, versus 26,568,875 shares and 163,301,188 options in the direct entry pre-change.

20-10-2026

ZTO Express (Cayman) Inc. furnished a Form 6-K for October 2026 that attaches Exhibit 99.1, a Next Day Disclosure Return dated October 16, 2026, and is signed by CFO Huiping Yan. The filing body contains no financial figures, operating metrics, or narrative disclosure beyond the cover page, exhibit index, and signature block, so the substantive content rests entirely in the unincluded exhibit.

• · Filing references Exhibit 99.1, a Next Day Disclosure Return dated October 16, 2026, which is not reproduced in the provided text, so its content cannot be verified here
• · Registrant files annual reports on Form 20-F rather than Form 40-F
• · Principal executive offices are in Shanghai, People's Republic of China (Qingpu District)
• · Commission File Number 001-37922

20-10-2026

Rapport Therapeutics reported positive topline results from its randomized, double-blind, placebo-controlled Phase 2 trial of RAP-219 in adults with acute mania associated with bipolar I disorder (253 patients). The primary endpoint was met with a 3.1-point placebo-adjusted improvement in YMRS total score at Week 3 (p=0.045), though the result is only marginally statistically significant and the trial showed a notably higher discontinuation rate on RAP-219 (24.6% vs 11.8% placebo), with withdrawal of consent as the leading reason (16.7% vs 4.7%). The Company plans an FDA End-of-Phase 2 meeting in Q1 2027 and expects to begin two Phase 3 trials in 2H 2027.

• · Week 1 and Week 2 placebo-adjusted YMRS improvements were 0.9 and 2.2 points, showing progressive but early-stage separation from placebo
• · Psychiatric TEAE incidence was slightly higher on RAP-219 (34.9%) than placebo (33.1%)
• · Treatment-related agitation was 3.2% on RAP-219 vs 1.6% placebo (all-cause agitation 16.7% RAP-219 vs 9.4% placebo)
• · Somnolence was reported less often with RAP-219 (0.8%) than placebo (3.1%)
• · Adverse effects common to current bipolar mania medications (orthostatic hypotension, akathisia, extrapyramidal symptoms) were not reported
• · Safety data from the eight-week post-treatment period will be presented at a future medical conference
• · Focal onset seizure long-term open-label extension initial data expected Q4 2026; PGTCS Phase 3 expected to begin 1H 2027; LAI Phase 1 PK data expected Q3 2027; RAP-641 Phase 1 preliminary results expected 2H 2027
• · Cash runway expected into 2H 2029, beyond expected Phase 3 FOS topline data

20-10-2026

Equinor ASA reported the buy-back of 389,058 of its shares on 15 October 2026 at a weighted average price of NOK 429.2415, for a total transaction value of NOK 166,999,840, as part of its share programmes for employees. Cumulative buy-backs under the programme now total 4,167,500 shares for NOK 1,469,846,959 at a weighted average price of NOK 352.6927. The purchases are routine employee share programme activity and do not signal a change in capital return policy.

• · The 15 October 2026 purchase price of NOK 429.2415 was roughly 24.5% above the accumulated weighted average of NOK 344.8107 for earlier purchases under the programme.
• · The programme's cumulative weighted average price of NOK 352.6927 is well below the price paid on 15 October, indicating recent purchases were made at higher prices than earlier ones.

20-10-2026

ING Groep N.V. filed a Form 6-K on October 20, 2026, furnishing a press release dated the same day as Exhibit 99.1, which is incorporated by reference. The filing body contains no financial figures, named initiatives, or substantive disclosures; the substance resides entirely in the unattached exhibit.

20-10-2026

Woori Financial Group Inc. filed a Form 6-K announcing that it will hold its 2026 Third Quarter Earnings Release Conference on Friday, October 23, 2026 at 16:00 Korea Time, with a live audio webcast and conference call, Q&A session, and materials posted on its website. The filing contains no financial results, so no period-over-period performance metrics are disclosed.

• · Conference date and time: Friday, October 23, 2026 at 16:00 Korea Time
• · Format: live audio webcast and conference call, with pre-registration available at pin.teletogether.com/eng
• · Languages: Korean and English, with simultaneous interpretation for English-speaking participants
• · Schedule is subject to change based on company circumstances

20-10-2026

Kimberly-Clark priced a private offering of $4.9 billion in senior unsecured notes across five tranches maturing 2028 to 2036, with closing expected on or about October 29, 2026. Proceeds, together with cash on hand and/or commercial paper borrowings, are earmarked to fund the cash consideration for the pending acquisition of Kenvue Inc., expected to close in Q4 2026. If the acquisition is not consummated by the outside date (five business days after the later of May 31, 2027 or any agreed extension), or if Kimberly-Clark abandons the deal, the notes must be redeemed at 101% of principal plus accrued interest.

• · Offering is not conditioned on consummation of the Kenvue acquisition, but notes carry a special mandatory redemption feature at 101% if the deal fails
• · Notes would be fully and unconditionally guaranteed by Kenvue if the acquisition closes and Kenvue exchange offers are not completed within four business days after their expiration
• · Exchange Offers and Consent Solicitations for Kenvue's existing senior notes commenced September 28, 2026; completion is not guaranteed on the described terms
• · Notes are unregistered and offered only to QIBs under Rule 144A and non-U.S. persons under Regulation S

20-10-2026

KE Holdings Inc. (BEKE) furnished a Form 6-K for October 2026 attaching five Next Day Disclosure Returns dated October 12 through October 16, 2026. The cover page and exhibit index do not disclose the substantive content of those returns, so no financial figures, operational metrics, or deal terms can be verified from this filing alone. The filing is administrative in nature and carries no quantifiable performance data.

• · Five Next Day Disclosure Returns (Exhibits 99.1-99.5) are attached, dated October 12, 13, 14, 15 and 16, 2026, respectively.
• · The filing is signed by CFO XU Tao on October 20, 2026.
• · The registrant is a Foreign Private Issuer filing under Form 20-F rather than Form 40-F.

20-10-2026

Synchrony Financial furnished its monthly charge-off and delinquency statistics for the thirteen months ended September 30, 2026 under Regulation FD (Item 7.01, Exhibit 99.1). The filing itself contains no specific numeric results; the figures reside in the exhibit, which was not included in the provided content. The company also stated it will continue monthly disclosure, with the last month of each quarter furnished alongside quarterly earnings.

• · Statistics cover the thirteen months ended September 30, 2026, and are furnished as Exhibit 99.1
• · Monthly cadence continues; the final month of each calendar quarter is released with quarterly earnings
• · Filing is furnished, not filed, and is not subject to Section 18 liability or incorporated by reference into other filings

20-10-2026

Artificial Intelligence Technology Solutions (AITX) furnished a press release projecting monthly operating cash breakeven beginning January 2027 and all-in cash breakeven (including debt service and device build expenditures) during Q2 2027. The projections assume approximately 2.7% monthly revenue growth, which the filing states exceeds the company's growth over the preceding twelve months, and expanded cash spend reductions of roughly $345,000 per month in January 2027 rising above $350,000 per month from February 2027, measured against the August 2026 expense run rate. The filing repeatedly cautions that the company has never been profitable, has a stockholders' deficit, carries a going-concern qualification, and depends on dilutive external financing, and that salary deferrals remain obligations rather than permanent savings.

• · Filing states the assumed 2.7% monthly revenue growth exceeds the company's growth over the preceding twelve months, and that recent sequential growth does not establish the rate will continue.
• · Projected cash savings include changes in payment timing, not only permanent expense reductions; salary deferrals and deferred compensation remain payable obligations.
• · Revenue recognized in a month does not equal cash collected, so financing may be needed even when projected revenue exceeds included expenditures.
• · Company states it does not qualify for the PSLRA safe harbor for forward-looking statements.
• · Auditor's report contains a going-concern substantial doubt paragraph; the company has never been profitable in any fiscal year and reports a stockholders' deficit and negative working capital.
• · Management measures (operating and all-in cash breakeven) are non-GAAP and do not imply GAAP profitability or elimination of accumulated liabilities.

20-10-2026

Fabrinet filed a DEFA14A (definitive additional proxy soliciting material) on October 20, 2026, supplementing its proxy materials for an upcoming shareholder meeting. The filing is a cover-page-only submission with the 'No fee required' box checked and no substantive proposals, financial figures, or voting details included in the excerpt provided.

• · Filed by the Registrant (Fabrinet), with the Definitive Additional Materials box checked rather than a preliminary or definitive proxy statement
• · No filing fee required for this submission
• · The excerpt contains only the cover page; the substantive supplemental content (proposals, meeting date, agenda items) is not included in the provided text

20-10-2026

POSCO Holdings Inc. filed a Form 6-K announcing that it will release provisional earnings for the third quarter of 2026 and its business plan on November 2, 2026 at 3:00 pm KST via conference call with analysts, institutional investors, and press, followed by a Q&A session. The filing contains no quantitative financial results, so no performance comparisons are available from this document.

• · Conference call scheduled for November 2, 2026 at 3:00 pm KST at POSCO Center, Seoul (venue listed as conference call)
• · Filing is a Form 6-K under Rule 13a-16 for the month of October 2026, filed by a foreign private issuer that files Form 20-F

20-10-2026

Zhihu Inc. furnished a Form 6-K for October 2026 attaching five Next Day Disclosure Returns dated October 12 through October 16, 2026. The filing itself contains only the cover page, exhibit index, and signature block; no financial results, deal terms, or operational figures are included in the body text provided.

• · Filing is made under Rule 13a-16 / 15d-16 of the Securities Exchange Act of 1934 as a foreign private issuer; registrant files annual reports on Form 20-F
• · Commission File Number 001-40253; principal executive offices in Beijing, PRC
• · Exhibit 99.1 to 99.5 are Next Day Disclosure Returns dated October 12, 13, 14, 15 and 16, 2026, which are typically Hong Kong Exchanges and Clearing filings; the substantive content of these exhibits is not reproduced in the provided text

20-10-2026

Harel Insurance Investments & Financial Services Ltd. filed a Schedule 13G reporting beneficial ownership of 2,424,529 Ordinary Shares of Elbit Systems Ltd (ESLT), representing 5.2% of the 46,848,460 shares outstanding as of June 17, 2026. The position is reported as passive (Rule 13d-1(c)), with the filer certifying the shares are not held to influence control of the issuer. Most of the reported shares (2,351,970) are held for public-fund and policyholder accounts managed by subsidiaries operating under independent management.

• · Filing is a LIVE Schedule 13G under Rule 13d-1(c), a passive-investor certification rather than an activist or control filing
• · Harel reports zero sole voting power and 2,424,529 shared dispositive power, with Item 4 noting independent management of underlying subsidiaries
• · Event date is 10/14/2026, with the filing made 10/20/2026

20-10-2026

Sea Limited filed a Form 6-K on October 20, 2026, attaching an internal email from Chairman and CEO Forrest Li to all employees marking the ninth anniversary of the company's initial public offering. The filing itself contains no financial results, guidance, or transaction details; it is a procedural submission of a non-financial internal communication to the SEC.

• · The 6-K attaches Exhibit 99.1, an employee email from the CEO dated October 20, 2026, referencing the ninth anniversary of Sea's IPO.
• · The filing includes standard forward-looking statement disclaimers and identifies Form 20-F as the annual report type (Form 40-F not checked).
• · No material financial, operational, or regulatory information is disclosed in the filing body.

20-10-2026

Northrop Grumman reported third quarter 2026 sales up 7 percent to $11.1 billion, with net earnings of $1.1 billion and diluted EPS of $7.89 versus $7.67 a year earlier. Backlog rose to $109.6 billion on $16.4 billion of net awards (book-to-bill of 1.5x), and the company raised its 2026 guidance for segment operating income and MTM-adjusted EPS. Performance was mixed: operating margin fell to 11.4 percent from 11.9 percent, segment operating margin fell to 12.1 percent from 12.3 percent, Defense Systems and Mission Systems operating income declined, and Mission Systems and Defense Systems margins compressed year over year.

• · Mission Systems operating margin rate fell to 15.8% from 16.7%, partly due to a prior-year $68M favorable EAC adjustment in restricted advanced microelectronics
• · Defense Systems operating margin rate fell to 10.8% from 11.4%, driven by a shift toward more cost-type contract content; Defense Systems organic sales were not affected by training services
• · Defense Systems and Space Systems lower armament/ammunition volume and Commercial Resupply Service sales (-$136M) were partial offsets
• · Effective tax rate declined to 13.4% from 16.9%, supported by higher research credits
• · Nine-month operating income rose 4% but unallocated corporate expense increased sharply to $250M from $17M, and nine-month Defense Systems operating income fell 11%
• · Nine-month Space Systems operating income declined 9% and Aeronautics Systems nine-month operating income rose 136%
• · Q3 operating cash flow benefited from improved trade working capital and a one-time $371M equipment sale proceeds to a customer, which flatter adjusted free cash flow
• · Guidance raised: segment operating income midpoint up $65M, MTM-adjusted EPS midpoint up $0.70; Aeronautics Systems margin guidance updated to high 9% from mid-to-high 9%

20-10-2026

Pacific Airport Group (GPAEF) reported 3Q26 consolidated total revenues of MXN 11,667,818 thousand, up 21.8% YoY, and 9M26 revenues of MXN 34,327,155 thousand, up 8.9%. Net income rose 8.1% in 3Q26 and 11.1% for 9M26, while the operating margin was flat at 43.3% in 3Q and EBITDA margin declined to 52.0% from 53.1%. Growth was driven by Cross Border Xpress (CBX) contributions and cargo, but aeronautical revenue grew only 2.6% in the quarter, and several airports (Los Cabos, Puerto Vallarta, Montego Bay, Guanajuato, Hermosillo) reported declining EBITDA or revenues. The balance sheet shows a sharp increase in goodwill/intangibles (MXN 37,926,450 thousand) and cash, alongside a large rise in bank loans and a MXN 12,512,864 thousand dividend payable, indicating a major transaction.

• · Montego Bay aeronautical revenues fell 28.2% in 3Q26 and 32.9% for 9M26, the steepest decline in the portfolio.
• · Technical assistance fees dropped 81.0% in 3Q26 (to MXN 43,001 thousand) and 89.4% for 9M26.
• · Concession taxes declined 13.8% in 3Q26, supporting margins despite higher revenues.
• · Consolidated Balance sheet shows goodwill/intangibles of MXN 37,926,450 thousand and premium on share subscription of MXN 35,766,611 thousand, consistent with a major equity/acquisition transaction.
• · Dividends payable of MXN 12,512,864 thousand were recorded at 9/30/2026, and current bank loans rose 286.5% YoY to MXN 19,434,447 thousand, indicating significant leverage increase.
• · Foreign currency translation reserve swung to a deficit of MXN (231,014) thousand from a MXN 95,577 thousand reserve.

20-10-2026

Copley Acquisition Corp (COPL-UN) has filed a definitive proxy statement for an extraordinary general meeting on October 29, 2026, seeking shareholder approval to extend its business combination deadline from November 2, 2026 up to 12 one-month extensions to November 2, 2027, funded by $150,000 per monthly extension deposited into the trust account as a non-interest bearing promissory note. The Trust account holds approximately $183.0 million, with a redemption price of about $10.61 per public share versus a NYSE closing price of $10.59, and the Board cautions that completion of a business combination within the extended period is not assured.

• · Extension Amendment requires a special resolution (two-thirds of votes cast by present/represented shares), and the Trust Agreement Amendment requires two-thirds of outstanding shares represented and voted.
• · Shareholders may redeem Public Shares regardless of how they vote; if the proposals fail, the company must redeem all Public Shares within 10 business days and dissolve.
• · Sponsor is not obligated to fund extensions, and warrants would expire worthless upon liquidation.
• · The Company may still choose not to exercise an extension and liquidate on the Termination Date even if the proposals are approved.
• · The existing charter allowed two three-month extensions (up to 24 months total), which the Extension Amendment would replace.

20-10-2026

This SC TO-I/A amendment, signed October 19, 2026 by Paul K. Danner as Principal Executive Officer, is an exhibit index update to a tender offer filing. Its content consists of a list of previously filed exhibits (underwriting agreement, warrant forms, equity plan, employment agreements, rights plan, and a filing fee table), most incorporated by reference to earlier 8-K, 10-Q and S-1 filings, and it reports no new financial results, offer terms, or quantitative figures. The document references a signatory entity named SkyAI, Inc., which differs from the registrant name provided (Sharps Technology Inc.), a discrepancy worth verifying.

• · Exhibit (a)(1)(H) is an email from MacKenzie Partners, Inc. to shareholders, and exhibits (a)(1)(G) and (a)(1)(I) are press releases dated October 14 and October 19, 2026, incorporated by reference to 8-K filings.
• · Exhibit 107 (Filing Fee Table) is the only exhibit filed with this amendment; all other exhibits are marked as previously filed.
• · Exhibit (d)(16) and (d)(17) reference amended and restated employment agreements dated May 13, 2026 with Alice Zhang and Paul K. Danner.
• · Exhibit (d)(26) references an employment agreement dated May 22, 2026 with Arthur Levine.
• · Exhibit (d)(24) references a Rights Plan dated May 14, 2026 with VStock Transfer LLC as rights agent.

20-10-2026

Midway Capital Research & Management (CIK 0002115416, Chicago, IL) filed a Form 13F-HR for the quarter ended September 30, 2026, disclosing 50 equity and ETF holdings with a combined reported market value of $118,092,577 (reported in thousands per 13F convention, i.e., approximately $118.09 billion as presented in the information table). Largest positions by reported value include Applied Materials ($13.85B), Brookfield Corp ($4.34B), Amphenol ($6.47B), Apple ($8.97B), and Alphabet Class A ($3.42B). The filing reports sole investment discretion over all positions, with no shared or other-manager holdings.

• · Filer SEC file number 028-26737; CIK 0002115416; filed as of October 20, 2026 with CONFORMED PERIOD OF REPORT 2026-09-30
• · All 50 holdings are reported with sole investment discretion (SOLE), with zero shared discretion and zero voting authority disclaimed; reported voting sole amount equals total shares for every position
• · Holdings include large concentrations in Applied Materials (27,083 shares), Brookfield Corp (119,133 shares), and Amphenol (76,694 shares) by share count
• · The portfolio includes three ETF/fund positions beyond individual equities: iShares 0-3 Month Treasury, iShares ESG Aware MSCI EAFE, and PIMCO Enhanced Short Maturity Active ETF, plus several Vanguard and WisdomTree funds
• · The filing is signed by Aryn Sands as Agent, dated October 19, 2026, from Reno, NV, with a business phone of 312-445-8562 listed in the header

20-10-2026

BioAtla, Inc. (BCAB) filed an S-1 registration statement dated October 20, 2026, that includes unaudited interim financial data for the six months ended June 30, 2026, alongside comparative periods for 2025 and 2024. The extracted content is almost entirely XBRL tagging metadata, so the specific income statement and balance sheet figures, including revenue, net loss, and cash position, cannot be reliably read from the provided text. The filing references a Standby Equity Purchase Agreement, a liquidity and going-concern discussion, a collaboration with BeiGene, and a pending transaction with Context Therapeutics, all of which point to material financing and liquidity considerations.

• · Filing contains going-concern and liquidity disclosures tied to the Standby Equity Purchase Agreement, signaling potential financing dependence.
• · Amended BeiGene collaboration and a Context Therapeutics transaction (with dates in May and August 2026) are referenced in the notes.
• · Filing references a December 2024 offering and pre-paid advance agreements, indicating prior capital-raising activity.
• · Specific revenue, net loss, and cash figures could not be extracted from the provided content, which consists largely of XBRL tags.

20-10-2026

Non Invasive Monitoring Systems (NIMU) filed an amended S-1 registration statement on October 20, 2026, tied to a pending merger agreement with Gravitics, Inc. (March 6, 2026, with an amended agreement dated August 5, 2026) and a subsequent event dated July 27, 2026. The excerpt is almost entirely XBRL tagging metadata, so specific operating results, revenue, and per-period changes cannot be reliably extracted; the filing shows related-party promissory notes with Frost Gamma Investments Trust and Dr. Jane Hsiao and a June 24, 2026 convertible promissory note purchase agreement.

• · Merger agreement with Gravitics, Inc. dated March 6, 2026, with an amended agreement referenced for August 5, 2026
• · Related-party promissory notes outstanding with Frost Gamma Investments Trust and Dr. Jane Hsiao, including a new promissory note agreement dated May 7, 2026
• · Convertible promissory note purchase agreement dated June 24, 2026, with stated minimum and maximum amounts not quantified in the excerpt
• · Preferred stock series (Series Seed, Series A, Series B redeemable convertible preferred) referenced across 2023 to 2026 equity statements
• · Subsequent event dated July 27, 2026 referenced in the filing, with details not present in the excerpt

20-10-2026

Retail Employees Superannuation Pty Ltd, as trustee for Retail Employees Superannuation Trust (Sydney, Australia), filed its Form 13F-HR for the quarter ended September 30, 2026, reporting 30 equity positions with an aggregate reported value of approximately $392.6 billion in the information table. Holdings are concentrated in mega-cap technology and AI-related names, led by Alphabet ($36.0B), NVIDIA ($45.3B), Apple ($24.2B), and Microsoft ($23.7B). The filing reports no period-over-period comparison, so changes versus the prior quarter cannot be assessed from this document.

• · Top five positions by reported value (NVIDIA, Alphabet, Apple, Microsoft, Broadcom) together account for roughly 40% of the total reported 13F value, indicating high concentration in large-cap technology.
• · Holdings include a notable cluster of software, data and analytics names (Synopsys, Tyler Technologies, Verisk, MSCI, Moody's), a portfolio tilt toward information services.
• · The filing lists 'Cintas Corp' and 'IDEXX Labs' under CUSIP 172908105 in the source text; the CUSIP shown is identical for two issuers, a likely data-entry issue to verify against EDGAR before relying on the table.
• · Amazon.com appears with 80,854 shares, while Microsoft is reported at 46,254 shares; share counts and values are reported as filed and were not cross-checked against market prices.

20-10-2026

Altium Investment Strategies LLC (Wesley Chapel, FL) filed a Form 13F-HR for the quarter ended September 30, 2026, reporting 25 equity and fund positions with a total reported value of approximately $87.4 million (87,420,020 in thousands of dollars per 13F convention). The portfolio is concentrated in broad-market and sector-tilted ETFs, with individual stock holdings in Alphabet, Amazon, Apple, Nvidia, ExxonMobil, Johnson & Johnson, Procter & Gamble, and Kopin Corp. The filing reports holdings only and contains no performance comparison between periods.

• · Largest single-issuer positions by reported value include ExxonMobil (~$109.6M), Apple (~$275.5M), Alphabet (~$641.6M) per the information table share and value columns
• · Portfolio includes exposure to crypto-linked vehicles (Grayscale Chainlink Trust ETF, Hyperliquid Strategies Inc) and gold exposure via First Trust Gold ETF
• · Filer uses sole investment discretion (SOLE) for all 25 reported positions with no shared or other-manager discretion reported
• · Form notes the filer's SEC file number is 028-26844 and the report covers the quarter ended September 30, 2026
• · Filing cover indicates no amendment (Form 13F-HR, not 13F-HR/A) and a single other included manager is not reported

20-10-2026

TAIYO LIFE INSURANCE CO filed a Form 13F-HR for the quarter ended September 30, 2026, reporting 11 equity positions, all held as sole investment discretion, consisting entirely of exchange-traded funds (ETFs) tracking U.S. equity indices and sectors. The aggregate reported holdings total approximately $1,118,328 thousand (per the cover page value field), with the largest positions concentrated in broad-market S&P 500 and technology sector exposures.

• · Filer is based in Chuo-ku, Tokyo, Japan, with a Form 13F-HR filed October 20, 2026 under SEC file number 028-18217
• · The Vanguard World Fund Information Technology ETF is the largest single position by share count (1,352,000 shares), though the S&P 500-tracking ETFs collectively represent the bulk of exposure
• · Holdings are concentrated in passive index ETFs, with no individual operating-company common stock positions reported
• · All positions are reported under sole investment discretion with no shared or other-manager discretion, and no other included managers are listed

20-10-2026

On October 17, 2026, Silgan Holdings signed a Transaction Agreement to form a partnership (MetalCo) with an AIP-affiliated investor, contributing its Metal Containers and Closures Business in exchange for 60% of MetalCo's Class A voting units. The A-VL Investor contributes $1.025 billion in cash for 40%, and Silgan receives a distribution of $2.263 billion less any new Silgan debt, of up to $1.0 billion. Concurrently, MetalCo obtained a put option to acquire Trivium Packaging B.V. for approximately $327.5 million in cash plus assumption of about $3.1 billion of Trivium debt, subject to consultation processes, antitrust clearance and an outside date of nine months from signing; the Transaction Agreement's closing outside date is October 15, 2027.

• · Put Option may be exercised only after works council consultations in France and the Netherlands and the Dutch Merger Code process are completed
• · Trivium Purchase Agreement equity value is fixed via a locked box mechanism as of December 31, 2025
• · Transaction Agreement may be terminated if the Closing has not occurred by October 15, 2027, or if the Put Option Agreement expires unexercised or the Trivium Purchase Agreement terminates
• · Fund IX provided a limited guarantee, subject to a cap, of certain A-VL Investor payment obligations under the Transaction Agreement
• · MetalCo will obtain representation and warranty insurance for the Trivium Purchase Agreement
• · Transaction and Trivium closings are conditioned on each other and on HSR and other antitrust clearances

20-10-2026

Fox Corporation announced that Adam Ciongoli, Chief Legal and Policy Officer, will not renew his contract and will step down effective December 1, 2026, transitioning to a special advisor role through June 2028. Nicholas Trutanich, currently Executive Vice President and Principal Deputy General Counsel, will become General Counsel effective the same date, reporting to Executive Chair and CEO Lachlan Murdoch. The change is a leadership succession within the legal function rather than a financial or operational event, with no financial metrics disclosed.

• · Kristopher Jones, EVP and Head of Government Relations, will report directly to John Nallen, President and COO, effective December 1, 2026
• · Trutanich previously served as U.S. Attorney for the District of Nevada (2019 to 2021) and joined Fox in 2021 as Chief Ethics & Compliance Officer
• · Ciongoli's advisory role runs through June 2028, providing continuity of institutional knowledge

20-10-2026

Annovis Bio, Inc. filed an 8-K to correct a typographical error in its June 17, 2026 annual meeting proxy statement regarding audit fees paid to Ernst & Young LLP. The corrected figures show total fees of $515,000 for 2025 and $482,045 for 2024, with audit fees rising from $375,000 to $415,000 (+10.7%) and audit-related fees declining from $107,045 to $100,000 (-6.6%).

• · Filing is a correction of a typographical error in the June 17, 2026 annual meeting proxy statement, not a new financial disclosure
• · Tax Fees and All Other Fees were nil in both years
• · Filed under Item 8.01 (Other Events) with Item 9.01 for the XBRL cover page exhibit
• · Company trades on the New York Stock Exchange under ANVS